Vertex Pharmaceuticals Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vertex Pharmaceuticals Inc with three other
companies in this sector in the United States:
Endo International PLC
sales of $2.95 billion
of which 34%
Elanco Animal Health Inc
of which 38%
was Food Animal Ruminants Swine), and
of which 72%
was Specialty Brands).
During the year ended December of 2018, sales at
Vertex Pharmaceuticals Inc were $3.05 billion.
increase of 22.5%
versus 2017, when the company's sales were $2.49 billion.
This was the fourth straight year of sales growth at Vertex Pharmaceuticals Inc.